Humasis Valuation

205470 Stock  KRW 1,612  18.00  1.10%   
At this time, the firm appears to be overvalued. Humasis retains a regular Real Value of W1435.77 per share. The prevalent price of the firm is W1612.0. Our model calculates the value of Humasis from evaluating the firm fundamentals such as Return On Equity of 117.34, return on asset of 0.41, and Current Valuation of 603.35 B as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
1,612
Please note that Humasis' price fluctuation is very steady at this time. Calculation of the real value of Humasis is based on 3 months time horizon. Increasing Humasis' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Humasis is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Humasis Stock. However, Humasis' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  1612.0 Real  1435.77 Hype  1612.0 Naive  1510.19
The real value of Humasis Stock, also known as its intrinsic value, is the underlying worth of Humasis Company, which is reflected in its stock price. It is based on Humasis' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Humasis' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
1,436
Real Value
1,773
Upside
Estimating the potential upside or downside of Humasis Co helps investors to forecast how Humasis stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Humasis more accurately as focusing exclusively on Humasis' fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1,5531,6371,721
Details
Hype
Prediction
LowEstimatedHigh
1,6091,6121,615
Details
Naive
Forecast
LowNext ValueHigh
1,5071,5101,513
Details

Humasis Total Value Analysis

Humasis Co is presently forecasted to have takeover price of 603.35 B with market capitalization of 425.94 B, debt of 2.25 B, and cash on hands of 176.58 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Humasis fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
603.35 B
425.94 B
2.25 B
176.58 B

Humasis Investor Information

The company had not issued any dividends in recent years. Based on the key indicators related to Humasis' liquidity, profitability, solvency, and operating efficiency, Humasis Co is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.

Humasis Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Humasis has an asset utilization ratio of 94.46 percent. This suggests that the Company is making W0.94 for each dollar of assets. An increasing asset utilization means that Humasis Co is more efficient with each dollar of assets it utilizes for everyday operations.

Humasis Ownership Allocation

Humasis Co has a total of 27.69 Million outstanding shares. Humasis retains 8.0 (percent) of its outstanding shares held by insiders and 0.26 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Humasis Profitability Analysis

The company reported the revenue of 321.83 B. Net Income was 151.2 B with profit before overhead, payroll, taxes, and interest of 30.85 B.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Humasis' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Humasis and how it compares across the competition.

About Humasis Valuation

The stock valuation mechanism determines Humasis' current worth on a weekly basis. Our valuation model uses a comparative analysis of Humasis. We calculate exposure to Humasis's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Humasis's related companies.
Ltd. develops, manufactures, and markets in-vitro diagnostics for the detection of cardiac marker, fertility hormone, infectious disease, tumor marker, and cotinine for home and laboratory use in South Korea and internationally. The company was founded in 2000 and is based in Anyang, South Korea. HUMASIS is traded on Korean Securities Dealers Automated Quotations in South Korea.

8 Steps to conduct Humasis' Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Humasis' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Humasis' valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Humasis' financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Humasis' revenue streams: Identify Humasis' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Humasis' industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Humasis' growth potential: Evaluate Humasis' management, business model, and growth potential.
  • Determine Humasis' financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Humasis' estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Complementary Tools for Humasis Stock analysis

When running Humasis' price analysis, check to measure Humasis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humasis is operating at the current time. Most of Humasis' value examination focuses on studying past and present price action to predict the probability of Humasis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humasis' price. Additionally, you may evaluate how the addition of Humasis to your portfolios can decrease your overall portfolio volatility.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.